Transdel explores strategic alternatives as it seeks funds to continue with topical ketoprofen
This article was originally published in Scrip
Executive Summary
Transdel Pharmaceuticals, a specialty pharmaceutical company developing topically delivery products based in La Jolla, California, is seeking either a deal or financing that could help it further develop its lead product, ketoprofen 10% topical cream, which utilises the firm's proprietary delivery platform designed to facilitate the effective penetration through the tough skin barrier.